Three specific formulations, designed to accompany every phase of the therapeutic journey: from the start of treatment through its maintenance, to the delicate phase following discontinuation.
GLP-1 receptor agonists have changed the way weight control and glycemic balance are managed, but their use is often accompanied by unwanted effects that can impact quality of life and adherence to therapy: gastrointestinal disturbances, fatigue, reduction in muscle mass, and, after discontinuation, a possible rapid regain of lost weight.
This is the origin of our new line: three complementary food supplements, each formulated to act at a specific moment in the therapeutic journey, supporting the overall wellbeing of the person undergoing treatment.
EuSide — Digestive comfort and energy
Formulated to support the initial and titration phases of therapy, when nausea, bloating, sluggish digestion, and fatigue are most common. A combination of ginger, prebiotic fibers, magnesium, B-vitamin complex, and phytosomal coenzyme Q10 helps support normal digestive system function and helps reduce tiredness and fatigue.

EuPower — Muscle tone and mass
Designed for the maintenance phase of treatment, when reduced caloric intake can be accompanied by a loss of lean mass as well as fat mass. A targeted intake of creatine, HMB, and vitamin D helps maintain muscle mass and supports normal muscle function.

EuStabil— Stability after discontinuation
Designed for the phase following treatment discontinuation, when the risk of rapid weight regain is highest. The formulation combines berberine, artichoke extract, FOS (fructooligosaccharides), and butyrate to support metabolism, liver function, and intestinal flora balance during the delicate transition period toward new, stable habits.

The three products in the line can be used individually, according to the need of the moment, or in sequence throughout the therapeutic journey, under the guidance of one’s trusted physician or pharmacist.